Skip to main content
Addgene

pZCS36 (Phsp16.41::Cas9(dpiRNA)::tbb-2 ‘3UTR)
(Plasmid #193048)

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 193048 Standard format: Plasmid sent in bacteria as agar stab 1 $85

Backbone

  • Vector backbone
    pUC19
  • Backbone manufacturer
    New England Biolabs
  • Backbone size w/o insert (bp) 2686
  • Total vector size (bp) 2686
  • Vector type
    Worm Expression, CRISPR

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    hsp16.41p::Cas9(dpiRNA)::tbb-2 ‘3UTR
  • Alt name
    Heat shock inducible Cas9
  • Species
    C. elegans (nematode)
  • Insert Size (bp)
    5168
  • Promoter hsp16.41p

Cloning Information

Resource Information

  • Supplemental Documents
  • A portion of this plasmid was derived from a plasmid made by
    hsp16.41 was derived from pMA122 acquired from Addgene, Cas9(dpiRNA)::tbb-2 was derived from pCFJ150-Cas9 acquired from Addgene

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.

Depositor Comments

How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pZCS36 (Phsp16.41::Cas9(dpiRNA)::tbb-2 ‘3UTR) was a gift from Patrick Phillips (Addgene plasmid # 193048 ; http://n2t.net/addgene:193048 ; RRID:Addgene_193048)
  • For your References section:

    High-throughput library transgenesis in Caenorhabditis elegans via Transgenic Arrays Resulting in Diversity of Integrated Sequences (TARDIS). Stevenson ZC, Moerdyk-Schauwecker MJ, Banse SA, Patel DS, Lu H, Phillips PC. Elife. 2023 Jul 4;12:RP84831. doi: 10.7554/eLife.84831. 10.7554/eLife.84831 PubMed 37401921